Levels of Epstein-Barr virus DNA in lymphoblastoid cell lines are correlated with frequencies of spontaneous lytic growth but not with levels of expression of EBNA-1, EBNA-2, or latent membrane protein

The process of Epstein-Barr virus (EBV)-induced transformation of human B lymphocytes results in a cell line that is a mixture of latently and lytically infected cells, with the lytic cells composing roughly 5% to less than 0.0001% of the overall population. A set of nine normal lymphoblastoid cell lines that span a 100- to 200-fold range in average EBV DNA content were studied, and the frequency with which these cells entered a lytic phase of viral growth correlated with their EBV DNA copy number (as a population average). However, neither factor correlated with the levels of expression of transcript for the viral genes EBNA-1, EBNA-2, and latent membrane protein, nor did they correlate with the levels of EBNA-2 protein and latent membrane protein. The rate at which a cell line enters into lytic growth spontaneously is therefore not dependent on the overall steady-state levels of expression of these latent-phase genes.

[1]  E. Kieff,et al.  Two related Epstein-Barr virus membrane proteins are encoded by separate genes , 1989, Journal of virology.

[2]  L. Heston,et al.  Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[3]  F. Studier,et al.  Analysis of restriction fragments of T7 DNA and determination of molecular weights by electrophoresis in neutral and alkaline gels. , 1977, Journal of molecular biology.

[4]  J. Ross.  A precursor of globin messenger RNA. , 1976, Journal of molecular biology.

[5]  G. Evan,et al.  Restricted expression of EBV latent genes and T‐lymphocyte‐detected membrane antigen in Burkitt's lymphoma cells. , 1986, The EMBO journal.

[6]  M. Epstein,et al.  Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji). , 1966, Journal of the National Cancer Institute.

[7]  P. Lieberman,et al.  Promiscuous trans activation of gene expression by an Epstein-Barr virus-encoded early nuclear protein , 1986, Journal of virology.

[8]  W. Hammerschmidt,et al.  Genetic analysis of immortalizing functions of Epstein–Barr virus in human B lymphocytes , 1989, Nature.

[9]  P. Leder,et al.  Globin gene expression in cultured erythroleukemic cells. , 1974, Journal of molecular biology.

[10]  E. Kieff,et al.  Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein , 1984, Journal of virology.

[11]  E. Kieff,et al.  Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[12]  E. Kieff,et al.  Epstein-Barr virus RNA. VIII. Viral RNA in permissively infected B95-8 cells , 1982, Journal of virology.

[13]  E. Kieff,et al.  RNA encoded by the IR1-U2 region of Epstein-Barr virus DNA in latently infected, growth-transformed cells , 1983, Journal of virology.

[14]  R. Weigel,et al.  Latent and viral replicative transcription in vivo from the BamHI K fragment of Epstein-Barr virus DNA , 1985, Journal of virology.

[15]  E. Kieff,et al.  Simple repeat sequence in Epstein-Barr virus DNA is transcribed in latent and productive infections , 1982, Journal of virology.

[16]  K. Takada,et al.  trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment , 1986, Journal of virology.

[17]  J. Countryman,et al.  Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[18]  E. Kieff,et al.  Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Yates,et al.  Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cells , 1985, Nature.

[20]  G. Miller,et al.  Recovery of Epstein-Barr virus from nonproducer neonatal human lymphoid cell transformants. , 1979, Virology.

[21]  V. Baichwal,et al.  Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus. , 1988, Oncogene.

[22]  R. Weigel,et al.  Major EB virus-specific cytoplasmic transcripts in a cellular clone of the HR-1 Burkitt lymphoma line during latency and after induction of viral replicative cycle by phorbol esters. , 1983, Virology.

[23]  F. Bach,et al.  Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[24]  V. Baichwal,et al.  Posttranslational processing of an Epstein-Barr virus-encoded membrane protein expressed in cells transformed by Epstein-Barr virus , 1987, Journal of virology.

[25]  P. Chavrier,et al.  Both Epstein‐Barr virus (EBV)‐encoded trans‐acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. , 1986, The EMBO journal.

[26]  D. Reisman,et al.  trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1 , 1986, Molecular and cellular biology.

[27]  E. Kieff,et al.  An Epstein-Barr virus transforming protein associates with vimentin in lymphocytes , 1987, Molecular and cellular biology.

[28]  W. Hammerschmidt,et al.  Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus , 1988, Cell.

[29]  L. Young,et al.  Differences in B cell growth phenotype reflect novel patterns of Epstein‐Barr virus latent gene expression in Burkitt's lymphoma cells. , 1987, The EMBO journal.

[30]  R. Pulvertaft.  A study of malignant tumours in Nigeria by short-term tissue culture , 1965, Journal of clinical pathology.

[31]  G. Klein,et al.  Inhibition of Epstein-Barr virus DNA synthesis and late gene expression by phosphonoacetic acid , 1976, Journal of virology.

[32]  S. Metzenberg.  Relative rates of RNA synthesis across the genome of Epstein-Barr virus are highest near oriP and oriLyt , 1989, Journal of virology.

[33]  A. Toscani,et al.  Normalization of multiple RNA samples using an in vitro-synthesized external standard cRNA. , 1987, Analytical biochemistry.

[34]  T. Iftner,et al.  Enhancement of Epstein-Barr virus membrane protein (LMP) expression by serum, TPA, or n-butyrate in latently infected Raji cells. , 1987, Virology.

[35]  P. Lieberman,et al.  A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen , 1988, Journal of virology.

[36]  V. Baichwal,et al.  The multiple membrane-spanning segments of the BNLF-1 oncogene from Epstein-Barr virus are required for transformation. , 1989, Oncogene.

[37]  G. Miller,et al.  Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[38]  M. Perricaudet,et al.  Epstein-Barr virus gene expression in P3HR1-superinfected Raji cells , 1987, Journal of virology.

[39]  B. Giovanella,et al.  An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection. , 1975, Intervirology.

[40]  J. Strominger,et al.  Isolation and characterization of cDNA clones corresponding to transcripts from the BamHI H and F regions of the Epstein-Barr virus genome , 1987, Journal of virology.

[41]  J. Strominger,et al.  Complex transcription of the Epstein-Barr virus BamHI fragment H rightward open reading frame 1 (BHRF1) in latently and lytically infected B lymphocytes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[42]  B. Barrell,et al.  Two related but differentially expressed potential membrane proteins encoded by the EcoRI Dhet region of Epstein-Barr virus B95-8 , 1985, Journal of virology.

[43]  E. Kieff,et al.  Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity , 1988, Journal of virology.

[44]  B. Sugden,et al.  Epstein-Barr virus DNA is amplified in transformed lymphocytes , 1979, Journal of virology.

[45]  D. Thorley-Lawson,et al.  Posttranslational processing of the Epstein-Barr virus-encoded p63/LMP protein , 1987, Journal of virology.

[46]  E. Southern.  Detection of specific sequences among DNA fragments separated by gel electrophoresis. , 1975, Journal of molecular biology.

[47]  D. Kemp,et al.  Method for detection of specific RNAs in agarose gels by transfer to diazobenzyloxymethyl-paper and hybridization with DNA probes. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[48]  B. Sugden,et al.  A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection , 1989, Journal of virology.

[49]  K. C. Reed,et al.  Rapid transfer of DNA from agarose gels to nylon membranes. , 1985, Nucleic acids research.

[50]  G. Hayward,et al.  Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region , 1985, Cell.

[51]  A. Levine,et al.  Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells , 1985, Molecular and cellular biology.

[52]  E. Kieff,et al.  The truncated form of the Epstein-Barr virus latent-infection membrane protein expressed in virus replication does not transform rodent fibroblasts , 1988, Journal of virology.

[53]  E. Kieff,et al.  Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells. , 1987, The Journal of general virology.

[54]  K. Takada,et al.  Both the rightward and the leftward open reading frames within the BamHI M DNA fragment of Epstein-Barr virus act as trans-activators of gene expression , 1987, Journal of virology.

[55]  I. Ernberg,et al.  Relationship between amount of Epstein–Barr virus-determined nuclear antigen per cell and number of EBV–DNA copies per cell , 1977, Nature.

[56]  E. Kieff,et al.  Simple repeat array in Epstein-Barr virus DNA encodes part of the Epstein-Barr nuclear antigen. , 1983, Science.

[57]  D. Melton,et al.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. , 1984, Nucleic acids research.

[58]  E. Kieff,et al.  An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells , 1985, Cell.

[59]  M. Perricaudet,et al.  A promoter for the highly spliced EBNA family of RNAs of Epstein-Barr virus , 1987, Journal of virology.

[60]  G. Milman,et al.  Epstein-Barr virus nuclear antigen forms a complex that binds with high concentration dependence to a single DNA-binding site , 1987, Journal of virology.

[61]  M. Belfort,et al.  The roles of the lambda c3 gene and the Escherichia coli catabolite gene activation system in the establishment of lysogeny by bacteriophage lambda. , 1974, Proceedings of the National Academy of Sciences of the United States of America.